期刊文献+

补肾骨宁汤对肾性骨病大鼠钙磷代谢的作用 被引量:4

Effect of Bushenguning Decoction on Calcium-phosphorus Metabolism of Rats with Experimental Renal Osteodystrophy
下载PDF
导出
摘要 目的观察补肾骨宁汤对肾性骨病大鼠钙磷代谢的作用。方法将60只大鼠随机分为假手术组(S组)、模型组(M组)、补肾骨宁汤高剂量组(H组)、补肾骨宁汤低剂量组(L组)、骨化三醇组(C组)。观察各组大鼠肾功能、血钙、磷、血清瘦素含量的变化。结果补肾骨宁汤能够降低肾性骨病大鼠血肌酐、尿素氮,提高肌酐清除率、血磷、血清瘦素含量。结论补肾骨宁汤能够改善肾性骨病大鼠肾功能,提高血磷、血清瘦素含量,治疗肾性骨病。 Objective To study the effect of Bushenguning decoction on calcium phosphorus metabolism in rats with experimental renal osteodystrophy. Methods The rats were randomly divided into sharn-operation group (S), model group (M), high-dose Bushenguning decoction group (H), low dose Bushenguning decoction group (L),calcitriol group (C),n = 12 in each group. Results Bushen guning decoction could redcue the serum level of serum creatinine, blood urea nitrogen, and increase creatinine clearance rate and the serum level of phosphorus and leptin in rats with renal osteodystrophy. Conclusions Bushenguning decoction can improve the renal function of rats with renal osteodystrophy and increase the the serum level of leptin.
出处 《临床肾脏病杂志》 2008年第8期375-377,共3页 Journal Of Clinical Nephrology
关键词 肾性骨病 补肾骨宁汤 钙磷代谢 Renal osteodystrophy disease Bushenguning decoction Calcium-phosphorus metabolism
  • 相关文献

参考文献5

二级参考文献39

  • 1Zhang Y,Proence R ,Maffei M ,et al. Positional cloning of the mouse obese gene and its human homologue.Nature 1994;372(6505) :425-32
  • 2Trayhurn P, Hoggard N,Mercer JG,et al.Leptin:fundamental aspects.Int J Obes Relat Metab Disord 1999;23(Suppl 1):22-8
  • 3Mryer C ,Robson D ,Rackovsky N,et al .Role of the kidney in human leptin metabolism.A m J Physiol 1997;273(5 Pt 1 ) :E903-7
  • 4Mantzoros CS,Moschos SJ.leptin:in search of role in human physiology and pathophysiology. Clin Endocrinol 1998;49(5):551-67
  • 5Ducy P ,Amling M,Takeda S ,et al .Leptin inhibits bone formation through a hypothalamic relay :a central control of bone mass. Cell 2000;100(2):197-207
  • 6Takeda S,Elefteriou F,Levasseur R,et al.Leptin regulates bone formation via the sympathetic nervous system. Cell 2002;111(3):305-17
  • 7Burguera B ,Hofbauer L C ,Thomas T ,et al. Leptin reduces ovariectomy induced bone loss in rats.Endocrinology 2001;142 (8) :3546 - 53
  • 8Steppan CM,Crawford DT ,Chidsey-Frink KL,et al .Leptin is a potent stimuIator of bone growth in ob/ob mice.Regul Pept 2000;92(1-3) :73-8
  • 9Thomas T,Gori F ,Khosla S ,et al. Leptin acts on human marrow stromal cells enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes .Endocrinology 1999; 140:1630-8
  • 10Reseland JE,Syversen U,Bakke I,et al.Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization.J Bone Miner Res 2001;16(8):1426-33

共引文献19

同被引文献65

  • 1安海燕,任可.补骨汤治疗肾性骨病的临床观察[J].中国中西医结合肾病杂志,2004,5(12):718-719. 被引量:13
  • 2陈祺,宣桂琪.矮小症的中医辨证论治[J].现代中西医结合杂志,2005,14(17):2307-2308. 被引量:15
  • 3赵继红.慢性肾衰竭患者继发性甲状旁腺功能亢进治疗现状[J].医学综述,2006,12(6):356-357. 被引量:5
  • 4Leonard M B. A structural approach to skeletal fragility in chronickidney disease//Seminars in nephrology. WB Saunders, 2009,29(2) :133-143.
  • 5Vervloet M G, Massy Z A, Brandenburg V M, et al. Bone:a newendocrine organ at the heart of chronic kidney disease and mineraland bone disorders. The Lancet Diabetes & Endocrinology, 2014,2(5):427-436.
  • 6赵志军.芪灵汤治疗肾性骨营养不良大鼠作用机制的实验研究.黑龙江省中医研究院,2010.
  • 7Moe S,Drueke T,Cunningham J. Definition,evaluation,and classification of renal osteodystrophy:a position statement from Kidney Disease:Improving Global Outcomes (KDIGO)[J].Kidney International,2006.1945-1953.
  • 8Jokihaara J,P(o)rsti IH,K(o)(o)bi P. Treatment of experimental renal osteodystrophy with pamidronate[J].Kidney International,2008,(03):319-327.doi:10.1038/ki.2008.180.
  • 9Price PA,Roublick AM,Williamson MK. Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate[J].Kidney International,2006,(09):1577-1583.doi:10.1038/sj.ki.5001841.
  • 10Sprague SM,Evenepoel P,Curzi MP. Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HCI[J].Clin J Am Soc Nephrol,2009,(09):1465-1476.doi:10.2215/CJN.06141108.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部